LENZ Therapeutics, Inc. (LENZ)
3.15
0.00 (0.00%)
USD |
NASDAQ |
Oct 27, 16:00
3.21
+0.06
(+1.90%)
After-Hours: 20:00
LENZ Therapeutics Free Cash Flow : -114.42M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -114.42M |
| March 31, 2026 | -87.44M |
| December 31, 2025 | -70.00M |
| September 30, 2025 | -46.16M |
| June 30, 2025 | -47.90M |
| March 31, 2025 | -52.08M |
| December 31, 2024 | -59.86M |
| September 30, 2024 | -71.60M |
| June 30, 2024 | -73.92M |
| March 31, 2024 | -71.54M |
| December 31, 2023 | -60.41M |
| September 30, 2023 | -62.89M |
| Date | Value |
|---|---|
| June 30, 2023 | -72.93M |
| March 31, 2023 | -82.86M |
| December 31, 2022 | -94.57M |
| September 30, 2022 | -87.70M |
| June 30, 2022 | -83.62M |
| March 31, 2022 | -74.68M |
| December 31, 2021 | -58.59M |
| September 30, 2021 | -47.90M |
| June 30, 2021 | -31.90M |
| March 31, 2021 | -18.68M |
| December 31, 2020 | -10.27M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Impact BioMedical, Inc. | -0.508M |
| Enveric Biosciences, Inc. | -8.561M |
| Liquidia Corp. | 150.69M |
| Aquestive Therapeutics, Inc. | -45.95M |
| ANI Pharmaceuticals, Inc. | 167.52M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -38.71M |
| Cash from Investing (Quarterly) | 37.75M |
| Cash from Financing (Quarterly) | 0.395M |
| Free Cash Flow Per Share (Quarterly) | -1.234 |
| Free Cash Flow to Equity (Quarterly) | -38.62M |
| Free Cash Flow to Firm (Quarterly) | -38.73M |
| Free Cash Flow Yield | -118.8% |